IDH1 MutationFase 2NCT06707493
Ivosidenib as Post-HSCT Maintenance for AML
Ivosidenib, Placebo
182 estudios de fase 2 reclutando ahora mismo, los actualizados más recientemente primero.
Abrir la página de fase 2 · una lista solo de esos estudios
Triangle is made by Triangle Health, Inc.
Leucemia, linfoma y mieloma182 estudios
IDH1 MutationFase 2NCT06707493
Ivosidenib, Placebo
Leucemia mieloide agudaFase 2NCT03586609Artículos
Azacitidine, Cladribine, Cytarabine, Venetoclax
Linfoma de células B grandesFase 2NCT06500273
cemacabtagene ansegedleucel, Fludarabine, Cyclophosphamide, Foresight CLARITY™ IUO MRD test, powered by PhasED-Seq™
Richter SyndromeFase 2NCT06863402
Biospecimen Collection, Bone Marrow Biopsy, Computed Tomography, Echocardiography
Linfoma de células del mantoFase 2NCT06252675
Obinutuzumab, Glofitamab, Pirtobrutinib, Tumor Imaging
T-Cell Large Granular Lymphocyte LeukemiaFase 2NCT05592015
Ruxolitinib
Waldenstrom MacroglobulinemiaFase 2NCT07231952
Pirtobrutinib, Venetoclax, Rituximab
Autologous Stem Cell TransplantFase 2NCT06377540
Pembrolizumab, Autologous stem cell transplant, Carmustine, Etoposide
T-cell Acute Lymphoblastic LeukemiaFase 2NCT06514794
WU-CART-007
Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaFase 2NCT07685717
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Computed Tomography
Follicular LymphomaFase 2NCT06350318
Zanubrutinib, Rituximab
Peripheral T Cell LymphomaFase 2NCT06630091
Golidocitinib, Cyclophosphamide, Doxorubicin, Vincristine
Hematological MalignanciesFase 2NCT04634552Artículos
Talquetamab
Mieloma múltipleFase 2NCT07149857
Cilta-cel, Cyclophosphamide, Induction therapy, Fludarabine
Follicular LymphomaFase 2NCT06563596
Zanubrutinib, Rituximab, Epcoritamab
Recurrent Acute Myeloid LeukemiaFase 2NCT03629171Artículos
Liposome-encapsulated Daunorubicin-Cytarabine, Venetoclax
Linfoma de células B grandesFase 2NCT06045247
Prednisone, Rituximab, Cyclophosphamide, Vincristine
B-Cell Lymphoblastic LeukemiaFase 2NCT06144606
Tecartus
B Cell LymphomaFase 2NCT06213311
Glofitamab, Obinutuzumab, Axi-cel
Mieloma múltipleFase 2NCT05789303
Belantamab mafodotin, Carfilzomib, Pomalidomide, Dexamethasone
Relapsed Classic Hodgkin LymphomaFase 2NCT04561206
Brentuximab Vedotin, Nivolumab
Recurrent Grade 1 Follicular LymphomaFase 2NCT06453044
Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging, Mosunetuzumab
Lymphoma, Non-HodgkinFase 2NCT02693535Artículos
Sunitinib (CLOSED TO ENROLLMENT), Trastuzumab and Pertuzumab (CLOSED TO ENROLLMENT), Vemurafenib and Cobimetinib (CLOSED TO ENROLLMENT), Olaparib (CLOSED TO ENROLLMENT)
Mieloma múltipleFase 2NCT04661137Artículos
Selinexor 60 MG, Selinexor 80 MG, Selinexor 100 MG, Carfilzomib